HAI or IV of Adebrelimab, Combined With Bevacizumab and HAI of FOLFOX for Advanced Unresectable Hepatocellular Carcinoma

NCT06737913 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

76

Enrollment

OTHER

Sponsor class

Conditions

Advanced Hepatocellular Carcinoma (HCC)

Interventions

PROCEDURE: HAI Adebrelimab
DRUG: intravenous infusion (IV) of Adebrelimab (ADE)
DRUG: intravenous infusion (IV) of Bevacizumab (Bev.)
PROCEDURE: HAIC with FOLFOX regimen
DRUG: Adebrelimab and bevacizumab maintainance treatment

Sponsor

Sun Yat-sen University

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]